Genomics changed cancer treatment. This company's investors are betting $165M it can work in infectious diseases, too.
February 24, 2020 at 09:11 AM EST
"This is the largest frontier genomics hasn't yet tackled," says the CEO of this company, which looks to double its workforce over the next year.
